G261-0751 Screening compound: N-({1-[(2,5-dimethylphenyl)methyl]piperidin-4-yl}methyl)-6-methyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamide

G261-0751 Screening compound: N-({1-[(2,5-dimethylphenyl)methyl]piperidin-4-yl}methyl)-6-methyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamide
G261-0751 Screening compound: N-({1-[(2,5-dimethylphenyl)methyl]piperidin-4-yl}methyl)-6-methyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G261-0751
N-({1-[(2,5-dimethylphenyl)methyl]piperidin-4-yl}methyl)-6-methyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G261-0751

Molecular Formula

C28H35N3O3S (C28 H35 N3 O3 S)

Compound Name

N-({1-[(2,5-dimethylphenyl)methyl]piperidin-4-yl}methyl)-6-methyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamide

IUPAC name

N-({1-[(25-dimethylphenyl)methyl]piperidin-4-yl}methyl)-6-methyl-4-oxo-2349-tetrahydro-1H-carbazole-7-sulfonamide

SMILES

Cc1cc(CN2CCC(CNS(c3c(C)cc4c(C(CCC5)=O)c5[nH]c4c3)(=O)=O)CC2)c(C)cc1

InChI

InChI=1S/C28H35N3O3S/c1-18-7-8-19(2)22(13-18)17-31-11-9-21(10-12-31)16-29-35(33,34)27-15-25-23(14-20(27)3)28-24(30-25)5-4-6-26(28)32/h7-8,13-15,21,29-30H,4-6,9-12,16-17H2,1-3H3

InChI Key

WRJAXWYVYOYWLY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14990532

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

493.67

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.200

Distribution Coefficient, logD

3.347

Water Solubility, LogSw

-5.12

Polar Surface Area

69.748

Acid Dissociation Constant (pKa)

11.73

Base Dissociation Constant (pKb)

9.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.40

G261-0751 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

CNS Targets (44014 compounds)

CORONAVIRUS Library (20774 compounds)

PLpro Library (6343 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with G261-0751 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G261-0751?
Check Price and Availability of G261-0751, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G261-0751 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G261-0751
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G261-0751
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G261-0751 available by request